发明名称 | Compositions and methods of treating retinal disease | ||
摘要 | Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed. | ||
申请公布号 | US9364471(B2) | 申请公布日期 | 2016.06.14 |
申请号 | US201414581453 | 申请日期 | 2014.12.23 |
申请人 | ALDEYRA THERAPEUTICS, INC. | 发明人 | Jordan Thomas A.;Dowling John E.;Chabala John Clifford |
分类号 | A61K31/47;A61K31/41;A61K31/423;A61K31/426;A61K31/435;A61K31/4706;C07C215/68;C07C229/56;C07C229/60;C07D215/38;C07D277/40;C07D277/56 | 主分类号 | A61K31/47 |
代理机构 | Dechert LLP | 代理人 | Reid Andrea L.C.;Dechert LLP |
主权项 | 1. A method of treating macular degeneration and other forms of retinal disease mediated by accumulation of A2E and/or lipofuscin in a subject, the method comprising administering to the subject in need thereof a composition comprising a compound of formula IIIa: or a pharmaceutically acceptable salt thereof, wherein: A is; B is a halogen atom, hydroxyl, carbamoyl, aryl or amino; p is 0, 1, 2, or 3; D is unbranched lower alkyl; L is a single bond or CH2; and X, Y, and Z are each, independently, N, NH, O, S, CB, CH, or absent, such that at least one of X, Y, and Z is N or NH; wherein X, Y, and Z and the carbon atoms to which they are attached form a 5- or 6-membered optionally substituted heterocyclic ring. | ||
地址 | Lexington MA US |